e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract: FAM13A gene confers reduced risk of COPD and lung cancer in current and former smokers
R. Young, R. Hopkins, B. Hay, C. Whittington, G. Gamble (Auckland, New Zealand)
Source:
Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Session:
Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Session type:
E-Communication Session
Number:
3547
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Young, R. Hopkins, B. Hay, C. Whittington, G. Gamble (Auckland, New Zealand). Late Breaking Abstract: FAM13A gene confers reduced risk of COPD and lung cancer in current and former smokers. Eur Respir J 2010; 36: Suppl. 54, 3547
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Late Breaking Abstract - The effects of smoking cessation and FAM13A gene susceptibility on lung function decline: A 16-year follow-up study among male smokers
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018
Association of the
PDCD5
locus with lung cancer risk and prognosis in smokers
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007
Late Breaking Abstract: Gene-based risk test for lung cancer risk motivates smoking cessation in randomly selected smokers
Source: Annual Congress 2010 - Smoking related disorders
Year: 2010
Cigarette smoke alters the EZH2/DAB2IP expression in bronchial epithelial cells. A risk factor for lung cancer in COPD patients
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
COPD prevalence in lung cancer patients – Is COPD a risk factor for lung cancer?
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Lymphopenia is linked to an increased incidence of cancer in smokers without COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Poor self regulation correlates with the incidence of lung cancer in smokers
Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis
Year: 2017
Lung cancer gene associated with COPD: triple whammy or possible confounding effect?
Source: Eur Respir J 2008; 32: 1158-1164
Year: 2008
COPD and lung cancer incidence in never smokers
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019
Novel genes associated with the level of FEV1 in never-smokers in the context of occupational exposure
Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD
Year: 2015
Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
TERT expression in lung cancer associated with IPF: a case-control study
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
Reduced FEV3/FVC identifies smokers at risk of developing COPD in the SPIROMICS cohort
Source: International Congress 2018 – Respiratory muscles and lung function: from healthy subjects to patients
Year: 2018
Identifying the at risk smokers: who goes on to get COPD?
Source: Eur Respir J, 54 (4) 1901613; 10.1183/13993003.01613-2019
Year: 2019
What is real prevalence of COPD in patients with lung cancer?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
COPD in patients with lung cancer and smoking
Source: Eur Respir J 2005; 26: Suppl. 49, 519s
Year: 2005
Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
The 15q24/25 susceptibility variant for lung cancer and COPD is associated with emphysema
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
Late Breaking Abstract: Improved prediction of COPD in patients at risk by lung function pre-screening in primary care
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010
Late Breaking Abstract - Endobronchial gene-expression clustering in COPD identifies a subgroup with higher level of lymphocytes and accelerated lung function decline
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept